Emerging

Semax for Dogs

Semax is a synthetic peptide analog of ACTH(4-10) — a fragment of adrenocorticotropic hormone. Developed in Russia at the Institute of Molecular Genetics, Semax has demonstrated potent neuroprotective and cognitive-enhancing effects. It is approved in Russia as a prescription medication for stroke recovery, cognitive impairment, and optic nerve conditions.

NeuroprotectiveCognitive EnhancementBrain HealthSenior CognitionBDNF

What Does the Research Say?

Semax has an extensive research record including significant enhancement of BDNF (brain-derived neurotrophic factor) — the primary growth factor for neurons, neuroprotective effects in stroke and brain injury models with improved functional recovery, cognitive enhancement across multiple measures (memory, attention, learning), modulation of dopamine and serotonin metabolism, and anti-inflammatory effects in neural tissue.

For dogs, Semax is most interesting for canine cognitive dysfunction (CCD) — the dog equivalent of dementia/Alzheimer's. CCD affects an estimated 28% of dogs aged 11-12 and 68% of dogs aged 15-16. Current treatments are limited (selegiline is the only FDA-approved drug for CCD). Semax's BDNF-enhancing and neuroprotective effects make it a compelling candidate for cognitive support in aging dogs, though canine-specific trials are needed.

Weight-Based Dosing Reference

⚠️ Important: Consult your veterinarian for dosing specific to your dog. This is reference information only.

SizeWeightBreeds
SmallUnder 25 lbsChihuahua, Dachshund, Pomeranian
Medium25–60 lbsBeagle, Border Collie, Cocker Spaniel
Large60–100 lbsLabrador, Golden Retriever, German Shepherd
GiantOver 100 lbsGreat Dane, Mastiff, Saint Bernard

🩺 Administration: Semax is administered intranasally (nasal drops or spray) or by subcutaneous injection. Intranasal is the standard route in clinical practice, providing direct access to the brain via the nasal mucosa. Oral bioavailability is negligible. Typically obtained through a compounding pharmacy with veterinary prescription.

Side Effects & Safety

Semax has a favorable safety profile based on decades of clinical use in Russia. It does not affect cortisol or ACTH levels despite being derived from an ACTH fragment — this was specifically engineered out of the peptide. Reported side effects are minimal: occasional nasal irritation (intranasal), mild headache (human reports), and transient changes in appetite. No serious adverse effects have been reported in published literature.

⚠️ Tumor Caution: Peptides promoting tissue repair could theoretically accelerate existing tumors. Vet screening recommended before starting, especially for seniors and cancer-prone breeds.

Where to Get Semax for Dogs

🏪 Integrative Peptides (Pettides)

Pet-specific oral supplements. US-made, ≥99% purity, vet-recommended.

Full Review →

🩺 Long Companion Labs

Vet telehealth + Rx peptides from a 503A compounding pharmacy.

Full Review →

Related Conditions

Anxiety & BehaviorSenior Dogs

FAQ

Can Semax help my senior dog with cognitive decline?

Semax enhances BDNF and has neuroprotective properties that may support cognitive function in senior dogs with canine cognitive dysfunction (CCD). It is an emerging option — discuss with a vet familiar with peptide therapy.

Is Semax the same as ACTH?

No. Semax is a modified fragment of ACTH that retains the nootropic and neuroprotective effects while the hormonal (cortisol-stimulating) activity has been engineered out. It does not affect cortisol or adrenal function.

How is Semax given to dogs?

Primarily intranasal (nasal drops) for direct brain access, or by subcutaneous injection. Oral administration is not effective due to very low bioavailability.

Veterinary Disclaimer: Educational only. Consult a licensed vet before starting any supplement. Affiliate Disclosure